These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


704 related items for PubMed ID: 23868476

  • 1. Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC, Royalty J, Helsel WE, Kammerer WG, Boehm JE, Dwyer DM, Howe WR, Joseph D, Lane DS, Laughlin M, Leypoldt M, Marroulis SC, Mattingly CA, Nadel MR, Phillips-Angeles E, Rockwell TJ, Ryerson AB, Tangka FK.
    Cancer; 2013 Aug 01; 119 Suppl 15():2820-33. PubMed ID: 23868476
    [Abstract] [Full Text] [Related]

  • 2. Outpatient colonoscopy complications in the CDC's Colorectal Cancer Screening Demonstration Program: a prospective analysis.
    Castro G, Azrak MF, Seeff LC, Royalty J.
    Cancer; 2013 Aug 01; 119 Suppl 15():2849-54. PubMed ID: 23868479
    [Abstract] [Full Text] [Related]

  • 3. Moving forward: using the experience of the CDCs' Colorectal Cancer Screening Demonstration Program to guide future colorectal cancer programming efforts.
    Seeff LC, DeGroff A, Joseph DA, Royalty J, Tangka FK, Nadel MR, Plescia M.
    Cancer; 2013 Aug 01; 119 Suppl 15():2940-6. PubMed ID: 23868488
    [Abstract] [Full Text] [Related]

  • 4. Lessons learned from the CDC's Colorectal Cancer Screening Demonstration Program.
    Seeff LC, Rohan EA.
    Cancer; 2013 Aug 01; 119 Suppl 15():2817-9. PubMed ID: 23868475
    [Abstract] [Full Text] [Related]

  • 5. Delivering colonoscopy screening for low-income populations in Suffolk County: strategies, outcomes, and benchmarks.
    Lane DS, Messina CR, Cavanagh MF, Anderson JC.
    Cancer; 2013 Aug 01; 119 Suppl 15():2842-8. PubMed ID: 23868478
    [Abstract] [Full Text] [Related]

  • 6. Assessing screening quality in the CDC's Colorectal Cancer Screening Demonstration Program.
    Nadel MR, Royalty J, Shapiro JA, Joseph D, Seeff LC, Lane DS, Dwyer DM.
    Cancer; 2013 Aug 01; 119 Suppl 15(0 15):2834-41. PubMed ID: 23868477
    [Abstract] [Full Text] [Related]

  • 7. Ontario's ColonCancerCheck: results from canada's first province-wide colorectal cancer screening program.
    Rabeneck L, Tinmouth JM, Paszat LF, Baxter NN, Marrett LD, Ruco A, Lewis N, Gao J.
    Cancer Epidemiol Biomarkers Prev; 2014 Mar 01; 23(3):508-15. PubMed ID: 24443406
    [Abstract] [Full Text] [Related]

  • 8. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
    Webendörfer S, Riemann JF.
    Dtsch Med Wochenschr; 2014 Jan 01; 139(3):79-83. PubMed ID: 24089288
    [Abstract] [Full Text] [Related]

  • 9. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
    van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.
    Gastroenterology; 2008 Jul 01; 135(1):82-90. PubMed ID: 18482589
    [Abstract] [Full Text] [Related]

  • 10. Outcomes and cost evaluation of the first two rounds of a colorectal cancer screening program based on immunochemical fecal occult blood test in northern Italy.
    Parente F, Boemo C, Ardizzoia A, Costa M, Carzaniga P, Ilardo A, Moretti R, Cremaschini M, Parente EM, Pirola ME.
    Endoscopy; 2013 Jul 01; 45(1):27-34. PubMed ID: 23254404
    [Abstract] [Full Text] [Related]

  • 11. Collaborating across multiple health care institutions in an urban colorectal cancer screening program.
    Villanueva R, Gugel D, Dwyer DM.
    Cancer; 2013 Aug 01; 119 Suppl 15():2905-13. PubMed ID: 23868485
    [Abstract] [Full Text] [Related]

  • 12. Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.
    Choi KS, Lee HY, Jun JK, Shin A, Park EC.
    J Gastroenterol Hepatol; 2012 Jun 01; 27(6):1070-7. PubMed ID: 22004224
    [Abstract] [Full Text] [Related]

  • 13. Clinical costs of colorectal cancer screening in 5 federally funded demonstration programs.
    Tangka FK, Subramanian S, Beebe MC, Hoover S, Royalty J, Seeff LC.
    Cancer; 2013 Aug 01; 119 Suppl 15(0 15):2863-9. PubMed ID: 23868481
    [Abstract] [Full Text] [Related]

  • 14. Use of colorectal cancer tests--United States, 2002, 2004, and 2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2008 Mar 14; 57(10):253-8. PubMed ID: 18340331
    [Abstract] [Full Text] [Related]

  • 15. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.
    J Natl Cancer Inst; 2007 Oct 03; 99(19):1462-70. PubMed ID: 17895475
    [Abstract] [Full Text] [Related]

  • 16. The effects of promoting colorectal cancer screening on screening utilisation: evaluation of the German Campaign "Aktiv gegen Darmkrebs" (Action against Colorectal Cancer).
    Loss J, Eichhorn C, Nagel E.
    Z Gastroenterol; 2006 Nov 03; 44(11):1127-34. PubMed ID: 17115353
    [Abstract] [Full Text] [Related]

  • 17. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening.
    Subramanian S, Tangka FKL, Hoover S, Royalty J, DeGroff A, Joseph D.
    Eval Program Plann; 2017 Jun 03; 62():73-80. PubMed ID: 28190597
    [Abstract] [Full Text] [Related]

  • 18. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ, Quintero E, Nicolás-Pérez D, Hernández-Guerra M, Parra-Blanco A, Jiménez-Sosa A.
    Eur J Gastroenterol Hepatol; 2009 Sep 03; 21(9):1062-7. PubMed ID: 19307978
    [Abstract] [Full Text] [Related]

  • 19. Trends in screening for colorectal cancer--United States, 1997 and 1999.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Mar 09; 50(9):162-6. PubMed ID: 11393486
    [Abstract] [Full Text] [Related]

  • 20. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F, Marino B, Ardizzoia A, Ucci G, Ilardo A, Limonta F, Villani P, Moretti R, Zucchi A, Cremaschini M, Pirola ME.
    Am J Gastroenterol; 2011 Nov 09; 106(11):1986-93. PubMed ID: 21670773
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 36.